AVBP icon

ArriVent BioPharma
AVBP

Overview Fund Trends Analyst Outlook Journalist POV

53 hedge funds and large institutions have $389M invested in ArriVent BioPharma in 2024 Q1 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$70.2M
2
+$54.1M
3
+$34.8M
4
OCA
Octagon Capital Advisors
New York
+$34.7M
5
SI
Sofinnova Investments
California
+$30.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$536K
27
$516K
28
$468K
29
$447K
30
$447K
31
$406K
32
$391K
33
$378K
34
$254K
35
$231K
36
$224K
37
$177K
38
$174K
39
$98.5K
40
$86.5K
41
$83.2K
42
$77.9K
43
$57.7K
44
$40.3K
45
$31.1K
46
$30K
47
$17.7K
48
$17.5K
49
$16.1K
50
$10.8K
1
2
3